MG

Musidipalli Gopal Rao

Director Director DIN 06707497
DIN 06707497 First appointment Oct 2013 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Musidipalli Gopal Rao

Data last updated:

Musidipalli Gopal Rao was a Director at Nucon Remedies Private Limited (2017–2018) and Director at Cheiron Biotech Private Limited (from 2013). The companies operate in Trading.

DIN 06707497
Primary Designation Director
Industry Trading
First Appointment 31 Oct 2013
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nucon Remedies Private Limited U51101MH2011PTC223199
Director20 Apr 20172011₹58.1 Lakh (FY 2025)Active
Cheiron Biotech Private Limited U24239CT2013PTC001131
Director31 Oct 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cheiron Biotech Private Limited
Nucon Remedies Private Limited
Premium access

Shareholding and investment profile for Musidipalli Gopal Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Musidipalli Gopal Rao

Musidipalli Gopal Rao was first appointed on 31 Oct 2013 as Director at Cheiron Biotech Private Limited. The most recent appointment on record is 20 Apr 2017 at Nucon Remedies Private Limited.

Musidipalli Gopal Rao held 2 earlier board appointments: Nucon Remedies Private Limited (Director, 20 Apr 2017 to 06 Dec 2018); Cheiron Biotech Private Limited (Director, from 31 Oct 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available